Form 4: Nevro Corp Director Michael F. DeMane Reports Changes in Beneficial Ownership

Director Michael F. DeMane reports acquisition and disposal of Nevro Corp stock, including shares held directly and indirectly through various trusts.

Summary

• On March 31, 2024, Michael F. DeMane, a director of Nevro Corp, reported changes in his beneficial ownership of the company's stock.
• He acquired 1,817 shares of common stock as fully vested restricted stock, representing quarterly retainer fees received in lieu of cash.
• The reported transactions leave Mr. DeMane with 33,205 directly owned shares, including 6,754 restricted stock units.
• He also indirectly owns shares through several trusts, including the Michael F. DeMane 2012 Irrevocable Trust (164,344 shares), the Michael F. DeMane 2017 Family SLAT Trust (122,541 shares), the Michael F. DeMane Revocable Trust (131,225 shares), and the Michael F. DeMane 2021 Retained Annuity Trust (18,266 shares).

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing, so the sentiment is neutral. It simply reports transactions.

Positives

• The acquisition of shares by a director can be seen as a positive signal, indicating confidence in the company's future.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the trading activities of company insiders.

Stakeholder Impact

• Shareholders may view the director's stock acquisition as a positive sign of confidence in the company.

Key Dates